Prestige Consumer Healthcare (PBH) Share-based Compensation (2010 - 2025)
Prestige Consumer Healthcare (PBH) posted quarterly Share-based Compensation of $2.7 million for Q4 2025, up 96.34% quarter-over-quarter from $1.4 million in Q3 2025.
Prestige Consumer Healthcare (PBH) Share-based Compensation (2010 - 2025) Analysis & Trends
Prestige Consumer Healthcare's Share-based Compensation history runs 16 years deep, the most recent figure standing at $2.7 million for Q4 2025.
- In Q4 2025, Share-based Compensation changed N/A year-over-year to $2.7 million; the TTM figure through Dec 2025 stood at $13.5 million (up 41.36% YoY), while the FY2025 annual figure was $11.2 million, down 20.36% from the prior year.
- Share-based Compensation for Q4 2025 stood at $2.7 million, up from $1.4 million in the prior quarter.
- The five-year high for Share-based Compensation was $5.3 million in Q1 2025, with the low at -$4.7 million in Q1 2021.
- The 5-year median for Share-based Compensation is $2.8 million (2021), against an average of $2.1 million.
- The sharpest annual moves came in 2021 and 2023: Share-based Compensation sank 339.65% in 2021, then jumped 231.88% in 2023.
- Prestige Consumer Healthcare's Share-based Compensation stood at $2.2 million in 2021, then slumped by 183.12% to -$1.9 million in 2022, then surged by 231.88% to $2.4 million in 2023, then slipped by 1.71% to $2.4 million in 2024, then climbed by 13.79% to $2.7 million in 2025.
- Business Quant data shows PBH's Share-based Compensation at $2.7 million in Q4 2025, $1.4 million in Q3 2025, and $4.1 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.27 Bn | 43.31 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.64 Bn | 39.99 Bn | 2.15 Bn | 40.00 Mn |
| 3 | Zoetis | 32.26 Bn | 30.58 Bn | 1.05 Bn | 26.00 Mn |
| 4 | Takeda Pharmaceutical | 28.68 Bn | 22.88 Bn | 5.10 Bn | 114.12 Mn |
| 5 | United Therapeutics | 22.29 Bn | 19.62 Bn | 683.80 Mn | 19.00 Mn |
| 6 | Viatris | 18.86 Bn | 17.98 Bn | 1.46 Bn | 30.40 Mn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 65.00 Mn |
| 8 | Elanco Animal Health | 11.96 Bn | 11.43 Bn | 798.00 Mn | 7.00 Mn |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - | - |
| 10 | Prestige Consumer Healthcare | 2.40 Bn | 2.34 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 2.74 Mn |
| Dec 31, 2025 | 2.74 Mn |
| Sep 30, 2025 | 1.40 Mn |
| Sep 30, 2025 | 1.40 Mn |
| Jun 30, 2025 | 4.05 Mn |
| Jun 30, 2025 | 4.05 Mn |
| Mar 31, 2025 | 5.33 Mn |
| Mar 31, 2025 | 5.33 Mn |
| Sep 30, 2024 | 2.41 Mn |
| Sep 30, 2024 | 2.41 Mn |
| Jun 30, 2024 | 3.43 Mn |
| Jun 30, 2024 | 3.43 Mn |
| Mar 31, 2024 | 3.73 Mn |
| Mar 31, 2024 | 3.73 Mn |
| Dec 31, 2023 | 2.45 Mn |
| Dec 31, 2023 | 2.45 Mn |
| Sep 30, 2023 | 3.69 Mn |
| Sep 30, 2023 | 3.69 Mn |
| Jun 30, 2023 | 4.15 Mn |
| Jun 30, 2023 | 4.15 Mn |